(201) 379-5660  |   aco@holyname.org

Public Reporting

ACO Name and Location:

North Jersey ACO, LLC
718 Teaneck Road
Teaneck, New Jersey 07666

ACO Primary Contact:

Emma Yamada
Director of Analytics
(201) 379-5660
yamada@holyname.org or eyamada@valleyhealth.com

Organizational Information:

ACO Participants

  • Amit Agarwal Md Pc
  • Arnold Schoen, MD
  • BIRCH TREE MEDICAL ASSOCIATES, PA
  • BREAST IMAGING PARTNERS, PC
  • Center For Dynamic Aging, Llc
  • CHANG W. LEE, MD
  • CHUL HYUN MD
  • CLIFFSIDE MEDICAL, LLC
  • CLOSTER INTERNAL MEDICINE, PC
  • Cohen Rosen & Kmieczak Dpm Pa
  • Conrado Boja Md Llc
  • David F Porter D.O., PA
  • Dr Chung Medical Clinic P C
  • EXCELCARE MEDICAL ASSOCIATES, PA
  • Foot & Ankle Therapy Pc
  • Gene Medical Group
  • General Surgery Practice Llc
  • Geriatrics And Internal Medicine Associates Of Northeast Llc
  • HANMI MEDICAL ASSOCIATES, PA
  • HANMI MEDICAL ASSOCIATES, PA
  • Hany A Sourial Md Pc
  • HEE K. YANG, MD
  • HOLY NAME CARDIOLOGY ASSOCIATES, PC
  • HOLY NAME MEDICAL ASSOCIATES PC
  • Holy Name Primary Care And Specialty Associates Pc
  • HOLY NAME PULMONARY ASSOCIATES, PC
  • House Physician Partners, P.C.
  • Irving Paltrowitz Md Joel Goldfarb Md M Schmidt Md P Micale Md Pa
  • KYU S. WANG MD, PC
  • Lois J Copeland Md Pa
  • MARC D. POLIMENI MD
  • METRO HEALTH, LLC
  • Mulkay Cardiology Consultants of Holy Name Medical Center, PC
  • North Jersey Infectious Disease Group Llc
  • NORTH JERSEY NEUROLOGY CARE, PA
  • North Jersey Orthopaedic Specialists P.A.
  • Pan S. Ko, MD, PC
  • Patrick T Clancy MD, PA
  • Peace Health Partners, Pc
  • Primary Care Of Oradell
  • Prospect Medical Office Llc
  • RADIATION ONCOLOGY PARTNERS, PC
  • Radiology Associates of Ridgewood, P.A.
  • Rehabilitation Specialists Of New Jersey, Llc
  • RICHARD JOO MD
  • Robert A Adair M D P A
  • Robert Degroote Md And Joseph Manno Md Pa
  • Sidney Rabinowitz, M.D., P.A.
  • Valley Diagnostic Medical Center
  • Valley Emergency Room Associates, PA
  • Valley Medical Services, P.C.
  • Valley Physician Services, Inc.
  • Valley Physician Services, NY, PC
  • Valley Physician Services, P.C.l
  • William K. Boss, jr. M.D. P.A.
  • WOMEN''S HEALTHCARE GROUP, PC
  • Woodcliff Lake Ophthalmology, LLP

ACO Participants in Joint Ventures between ACO Professionals and Hospitals

  • No participants are involved in a joint venture between ACO professionals and hospitals.

ACO Governing Body

  • Adam Jarrett, MD; Voting Member and Chair, ACO Participant, Holy Name Primary Care And Specialty Associates PC
  • Robert Brenner, MD; Voting Member, ACO Participant, The Valley Hospital, Inc.
  • Thomas Birch, MD; Voting Member, ACO provider/supplier, Birch Tree Medical Associates PA
  • Donna Fry, RN; Voting Member, ACO Participant, The Valley Hospital, Inc.
  • Marc Goldstein; Voting Member, ACO Participant, The Valley Hospital, Inc.
  • Alexander Hesquijarosa; Voting Member, ACO provider/supplier, Excelcare Medical Associates, PA
  • Richard Lucaine, MD; Voting Member, ACO provider/supplier, Valley Diagnostic Medical Center
  • Sean O'Rourke; Voting Member, ACO Participant, Holy Name Medical Center, Inc.
  • David Strassberg, MD; Voting Member, Valley Physician Services, Inc.
  • Richard Van Eerde; Voting Member, ACO Participant, Holy Name Medical Center, Inc.
  • Charles Berkowitz; Voting Member, Medicare Beneficiary Representative

Key ACO Clinical and Administrative Leadership

  • ACO Executive: Adam Jarrett, MD, MS
  • Medical Director: Richard Lucaine, MD
  • Compliance Officer: Nicole Kovolenko, MHA
  • Quality Assurance/Improvement Officer: Thomas Birch, MD

Associated Committees and Committee Leadership

  • Finance Committee: Bill Klutkowski; Chair
  • Physician Advisory Committee: Richard Lucaine, MD; Chair
  • Quality and Performance Improvement Committee: Thomas Birch, MD; Chair

Types of ACO Participants, or Combinations of Participants, that Formed the ACO

  • ACO professionals in a group practice arrangement
  • Network of individual practices of ACO professionals
  • Partnership or joint venture arrangements between hospitals and ACO professionals.

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Agreement period beginning 2013, Performance Year 1: $0
  • Agreement period beginning 2013, Performance Year 2014: $0
  • Agreement period beginning 2013, Performance Year 2015: $0

Shared Savings Distribution

  • Agreement period beginning 2013, Performance Year 1: $0
  • Agreement period beginning 2013, Performance Year 2014: $0
  • Agreement period beginning 2013, Performance Year 2015: $0
  • Proportion invested in infrastructure: Not Yet Determined
  • Proportion invested in redesigned care processes/resources: Not Yet Determined
  • Proportion of distribution to ACO participants: Not Yet Determined

Payment Rule Waivers

  • North Jersey ACO does not utilize the SNF 3-day Rule Waiver.

2015 Quality Performance Results Table

Measure number

Measure Name

2015 reporting period

ACO
performance rate

Mean performance rate (SSP- ACOs)

ACO-1

CAHPS: Getting Timely Care, Appointments, and Information

72.82

80.61

ACO-2

CAHPS: How Well Your Providers Communicate

90.47

92.65

ACO-3

CAHPS: Patients' Rating of Provider

89.60

91.94

ACO-4

CAHPS: Access to Specialists

78.94

83.61

ACO-5

CAHPS: Health Promotion and Education

58.51

59.06

ACO-6

CAHPS: Shared Decision Making

68.38

75.17

ACO-7

CAHPS: Health Status/Functional Status

72.01

72.30

ACO-34

CAHPS: Stewardship of Patient Resources*

28.06

26.87

ACO-8

Risk Standardized, All Condition Readmission

15.93

14.86

ACO-35

Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)*
Readmission

19.36

18.07

ACO-36

All-Cause Unplanned Admissions for Patients with Diabetes*

63.64

54.60

ACO-37

All-Cause Unplanned Admissions for Patients with Heart Failure*

82.77

76.96

ACO-38

All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions

68.90

62.92

ACO-9

Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)

1.91

1.11

ACO-10

Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8)

1.29

1.04

ACO-11

Percent of Primary Care Physicians who Successfully Meet Meaningful Use
Requirements

39.02%

76.22%

ACO-39

Documentation of Current Medications in the Medical Record*

64.89%

84.07%

ACO-13

Falls: Screening for Future Fall Risk

34.16%

56.46%

ACO-14

Preventive Care and Screening: Influenza Immunization

41.00%

62.03%

ACO-15

Pneumonia Vaccination Status for Older Adults

34.49%

63.73%

ACO-16

Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-up

51.74%

71.15%

ACO-17

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

76.69%

90.16%

ACO-18

Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan

22.51%

45.25%

ACO-19

Colorectal Cancer Screening

43.98%

60.06%

ACO-20

Breast Cancer Screening

46.10%

65.67%

ACO-21

Preventive Care and Screening: Screening for High Blood Pressure and
Follow-Up Documented

50.68%

70.04%

ACO-40

Depression Remission at Twelve Months*

N/A

N/A

ACO-27

Diabetes Mellitus: Hemoglobin A1c Poor Control

21.69%

20.38%

ACO-41

Diabetes: Eye Exam*

20.35%

41.05%

ACO-28

Hypertension: Controlling High Blood Pressure

66.92%

69.62%

ACO-30

Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic

71.20%

83.82%

ACO-31

Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

62.89%

87.22%

ACO-33

Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)

67.50%

77.73%

CAHPS = Consumer Assessment of Healthcare Providers and Systems, PQI = Prevention Quality Indicator, LVSD = left ventricular systolic dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery disease.

*= Measure required beginning Reporting Year 2015.

N/A= Reporting on the depression remission measure is not required for 2015, as indicated by N/A


2012-2014 Quality Performance Results Table

Measure number

Performance measure

2012 reporting period

2013 reporting period

2014 reporting period

ACO performance rate

Mean performance rate for all ACOs

ACO performance rate

Mean performance rate for all ACOs

ACO performance rate

Mean performance rate for all ACOs

ACO-1

Getting Timely Care, Appointments, and Information

Not in operations

Not in operations

75.70

80.13

ACO-2

How Well Your Doctors Communicate

Not in operations

Not in operations

91.25

92.39

ACO-3

Patients' Rating of Doctor

Not in operations

Not in operations

89.75

91.85

ACO-4

Access to Specialists

Not in operations

Not in operations

88.76

83.97

ACO-5

Health Promotion and Education

Not in operations

Not in operations

56.19

58.29

ACO-6

Shared Decision Making

Not in operations

Not in operations

73.81

74.60

ACO-7

Health Status/Functional Status

Not in operations

Not in operations

71.23

71.10

ACO-8

Risk Standardized, All Condition Readmissions

Not in operations

Not in operations

15.77

14.90

15.72

15.15

ACO-9

ASC Admissions: COPD or Asthma in Older Adults

Not in operations

Not in operations

1.45

1.17

1.61

1.08

ACO-10

ASC Admission: Heart Failure

Not in operations

Not in operations

1.35

1.20

1.41

1.19

ACO-11

Percent of PCPs who Qualified for EHR Incentive Payment

Not in operations

Not in operations

39.47

66.21

53.85

76.71

ACO-12

Medication Reconciliation

Not in operations

Not in operations

87.12

82.61

ACO-13

Falls: Screening for Fall Risk

Not in operations

Not in operations

29.14

45.60

ACO-14

Influenza Immunization

Not in operations

Not in operations

44.59

57.51

ACO-15

Pneumococcal Vaccination

Not in operations

Not in operations

30.89

55.03

ACO-16

Adult Weight Screening and Follow-up

Not in operations

Not in operations

52.62

66.75

ACO-17

Tobacco Use Assessment and Cessation Intervention

Not in operations

Not in operations

64.68

86.79

ACO-18

Depression Screening

Not in operations

Not in operations

20.68

39.27

ACO-19

Colorectal Cancer Screening

Not in operations

Not in operations

46.69

56.14

ACO-20

Mammography Screening

Not in operations

Not in operations

38.56

61.41

ACO-21

Proportion of Adults who had blood pressure screened in past 2 years

Not in operations

Not in operations

65.78

60.24

ACO-22

Hemoglobin A1c Control (HbA1c) (<8 percent)

Not in operations

N/A

N/A

69.67

N/A

ACO-23

Low Density Lipoprotein (LDL) (<100 mg/dL)

Not in operations

N/A

N/A

N/A

N/A

ACO-24

Blood Pressure (BP) <140/90

Not in operations

N/A

N/A

72.99

N/A

ACO-25

Tobacco Non Use

Not in operations

N/A

N/A

68.30

N/A

ACO-26

Aspirin Use

Not in operations

N/A

N/A

64.46

N/A

ACO-27

Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent)

Not in operations

Not in operations

20.94

20.35

ACO-28

Percent of beneficiaries with hypertension whose BP <140/90

Not in operations

Not in operations

72.03

68.02

ACO-29

Percent of beneficiaries with IVD with complete lipid profile and LDL control <100mg/dl

Not in operations

Not in operations

N/A

N/A

ACO-30

Percent of beneficiaries with IVD who use Aspirin or other antithrombotic

Not in operations

Not in operations

84.42

80.79

ACO-31

Beta-Blocker Therapy for LVSD

Not in operations

Not in operations

82.35

82.71

ACO-32

Drug Therapy for Lowering LDL Cholesterol

Not in operations

N/A

N/A

N/A

N/A

ACO-33

ACE Inhibitor or ARB Therapy for Patients with CAD and Diabetes and/or LVSD

Not in operations

N/A

N/A

81.38

N/A